Bristol Myers Squibb (BMY) Return on Capital Employed Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) Return on Capital Employed Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 843.00
Dec 31, 2025 1,153.00
Sep 30, 2025 -235.00
Jun 30, 2025 -378.00
Mar 31, 2025 -509.00
Dec 31, 2024 -2,810.00
Sep 30, 2024 -2,498.00
Jun 30, 2024 -2,534.00
Mar 31, 2024 -2,165.00
Dec 31, 2023 -107.00
Sep 30, 2023 274.00
Jun 30, 2023 733.00
Mar 31, 2023 394.00
Dec 31, 2022 44.00
Sep 30, 2022 -149.00
Jun 30, 2022 -415.00
Mar 31, 2022 -694.00
Dec 31, 2021 -589.00
Sep 30, 2021 -1,606.00
Jun 30, 2021 -1,412.00